Literature DB >> 1309252

The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.

P R Kinchington1, J K Hougland, A M Arvin, W T Ruyechan, J Hay.   

Abstract

Varicella-zoster virus (VZV) open reading frame (ORF) 62 potentially encodes a protein with considerable amino acid homology to the herpes simplex virus (HSV) immediate-early regulatory polypeptide ICP4 (or IE3). To identify and characterize its protein product(s) (IE62), we used a rabbit antiserum prepared against a synthetic peptide corresponding to the C-terminal 13 amino acids of the predicted protein. This antiserum reacted with phosphorylated polypeptides of 175 to 180 kDa that were made in VZV-infected cells and in cells infected with a vaccinia virus recombinant expressing IE62, but not in control-infected cells, confirming its specificity and reactivity to the IE62 protein. The antiserum recognized a 175-kDa polypeptide in purified virions that comigrated with a major structural protein. Comparison of this reactivity with that of an antipeptide antiserum directed against the VZV ORF 10 product (homologous to the HSV major structural protein VP16) indicates similar levels of ORF 62 and ORF 10 polypeptides in VZV virions. In contrast, antipeptide antiserum directed against the VZV ORF 29 product, the homolog of the HSV major DNA-binding protein, failed to recognize any protein in our virion preparations. Treatment of virions with detergents that disrupt the virion envelope did not dissociate IE62 from the nucleocapsid-tegument structure of the virion. Differential sensitivity of VZV virion IE62 to trypsin digestion in the presence or absence of Triton X-100 indicates that IE62 is protected from trypsin degradation by the virus envelope; since it is not a nucleocapsid protein, we conclude that it is part of the tegument. Finally, we show that the virion 175-kDa protein either can autophosphorylate or is a major substrate in vitro for virion-associated protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309252      PMCID: PMC238295     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

2.  Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16.

Authors:  S J Triezenberg; K L LaMarco; S L McKnight
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

3.  Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.

Authors:  P R Kinchington; J Remenick; J M Ostrove; S E Straus; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

4.  Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4.

Authors:  D M Knipe; D Senechek; S A Rice; J L Smith
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  The immediate early proteins of varicella-zoster virus.

Authors:  K Shiraki; R W Hyman
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

6.  Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.

Authors:  J M Felser; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA.

Authors:  S W Faber; K W Wilcox
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

8.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

9.  Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1.

Authors:  J M Felser; P R Kinchington; G Inchauspe; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate-early gene expression.

Authors:  P O'Hare; C R Goding; A Haigh
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  83 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 3.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

4.  Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.

Authors:  J I Cohen; K Seidel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.

Authors:  Heidi J Zapata; Masako Nakatsugawa; Jennifer F Moffat
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Authors:  P R Kinchington; J P Vergnes; P Defechereux; J Piette; S E Turse
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

Authors:  S Debrus; C Sadzot-Delvaux; A F Nikkels; J Piette; B Rentier
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies.

Authors:  G B Caughman; J B Lewis; R H Smith; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.